Alkem Laboratories Ltd (BOM:539523)
₹ 5501.35 -117.95 (-2.1%) Market Cap: 658.01 Bil Enterprise Value: 629.50 Bil PE Ratio: 32.04 PB Ratio: 6.38 GF Score: 98/100

Q1 2022 Alkem Laboratories Ltd Earnings Call Hosted by Motilal Oswal Securities Ltd Transcript

Aug 06, 2021 / 11:00AM GMT
Release Date Price: ₹3471.55 (+2.20%)
Operator

Good day, ladies and gentlemen, and a very warm welcome to the Alkem Laboratories Q1 FY '22 Earnings Conference Call, hosted by Motilal Oswal Financial Services Limited. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Tushar Manudhane from Motilal Oswal. Thank you, and over to you, Tushar.

Tushar Manudhane
Motilal Oswal Securities Limited, Research Division - Research Analyst

Thanks, Ali. Welcome to Q1 FY '22 earnings call of Alkem Laboratories. From the management side, we have Mr. Sandeep Singh, Managing Director; Mr. Rajesh Dubey, Chief Financial Officer; Mr. Amit Ghare, President, International Business; Mr. Yogesh Kaushal, President, Chronic Diseases; and Mr. Gagan Borana from the Investor Relations.

Over to you, Gagan, for the opening remarks.

Gagan Borana
Alkem Laboratories Limited - General Manager of IR

Thank you, Tushar. Good evening, everyone, and thank you for your joining us today for our Q1 FY '22 earnings call.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot